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IL-1f3 regulates rat mesangial cyclooxygenase II gene expression
by tyrosine phosphorylation
DANUTA M. RZYMKIEWICZ, JESSICA DUMAINE, and AUBREY R. MORRISON
Departments of Medicine and Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, Missouri USA
IL-1 regulates rat mesangial cyclooxygenase II gene expression by
tyrosine phosphorylation. The pro-inflammatory cytokine, interleukin-1p,
induces the mRNA for prostaglandin endoperoxide synthase II gene in
renal mesangial cells. This inductive effect is selective for prostaglandin
endoperoxide synthase II and not prostaglandin endoperoxide synthase I.
In the present experiments IL-113 increased COX II mRNA, and this was
inhibited by genistein and herbimycin A, both inhibitors of protein
tyrosine kinases. The dose dependent effect of genistein on inhibition of
mRNA for COX II correlated with the inhibition of the release of PGE2
into the media. Induction of COX II by interleukin-1j3 was mimicked by
incubating the cells in the presence of a protein tyrosine phosphatase
inhibitor, vanadate. These experiments also illustrate selective induction
of COX II mRNA without induction of COX I mRNA. Western analysis
utilizing antiphosphotyrosine antibodies demonstrated in whole lysates of
mesangial cells treated with interleukin-113 that the transient phosphory-
lation of several proteins occurred. Interleukin-1/3 induced the transient
phosphorylation of a protein of about 39/40 kD. Similarly, vanadate also
produced a rapid and transient phosphorylation of a protein of about
39/40 kD in addition to other proteins. Immunoprecipitation of mesangial
cell lysates with agarose conjugated antiphosphotyrosine antibody and
Western analysis of precipitated proteins with anti-ERK2 antibody dem-
onstrate that the 39/40 kD protein phosphoiylated on tyrosine is ERK2
and suggests participation of one of the MAP kinase family of extracellular
receptor kinases iii IL-1f3 stimulated induction of the COX II gene.
Interleukin-1/3 (IL-1/3) is a major mediator of the inflammatory
response. It is synthesized as an inactive precursor by monocytes,
endothelial cells, and a number of other tissues [1]. Recently, a
human cystine protease has been described that converts the 31
kD inactive IL-I precursor to the 17.5 kD mature active IL-I f3 by
cleaving between Asp 116 and Ala 117 [2—4]. Monocytes appear
to release IL-113 extracellularly in response to several activating
signals and cell injury leading to necrosis [5, 6]. This released
IL-1j3 interacts with cells with two types of binding molecules: the
IL-i type I receptor (IL-i RI) and IL-i type II receptor (IL-i Ru)
[7—9]. While the function of IL-i Ru is unknown, it appears that
IL-4 antagonizes the action of IL-i by inducing expression and
release of IL-i Rh in polymorphonuclear leukocytes [10]. It has
also been suggested that dexamethasone also induces expression
and release of the IL-i Rh receptor in polymorphonuclear
leukocytes [10]. Thus, the experimental data suggest that IL-i can
act on a number of responsive cells through the IL-i RI receptor
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and that IL-i Rh receptor inhibits IL-i activity by acting as a
decoy target for IL-i. The binding of IL-1(3 to its receptor, and
particularly the IL-i RI receptor, initiates a series of biological
and biochemical responses in receptive cells and triggers a
number of biochemical processes which include tyrosine phos-
phorylation [11, 12], serine/threonine phosphorylation [13, 14],
and the activation of a ceramide activated kinase [151. The last is
one of the family of proline directed serine/threonine kinase [16].
In addition, the formation of ceramide intracellularly could
potentially activate directly or indirectly a cytosolic protein phos-
phatase [17]. In the experimental system which we have been
evaluating, it is clear that interleukin-1f3 induces the message for
prostaglandin endoperoxide synthetase-2 (COX II) in the rat
mesangial cell [18]. This effect is dose dependent and results in a
dramatic up-regulation of the prostaglandin E2 secreted into the
media by these cells in response to interleukin-1f3 [19]. This
increase of PGE2 into the media occurs after a lag of about 6
hours [18], which is probably dependent on cellular synthesis of
the active COX II protein. In an attempt to understand the signal
transduction mechanisms involved in this biological response, we
have evaluated the role of tyrosine phosphosylation. Since the
IL-1f3 receptor is not known to express intrinsic tyrosine kinase
activity, a role for non-receptor tyrosine kinases is likely. The
current experiments suggest that tyrosine phosphorylation is an
integral and fundamental part of the signaling pathway of inter-
leukin-1f3 leading to the expression of the prostaglandin endoper-
oxide synthetase-2 gene in the rat mesangial cell. However, this
response requires a serum factor(s) to prime the cells for full
expression of this response.
Methods
Cell culture
Primary mesangial cell cultures were prepared from male
Sprague-Dawley rats as previously described [3]. Cells were grown
in RPMI-1640 medium supplemented with 15% (vol/vol) heat-
inactivated fetal calf serum 0.6% (vol/vol) insulin, 100 U/ml
penicillin, 100 g/ml streptomycin, 250 g/ml fungizone, and 15 mvt
HEPES. All experiments were performed with confluent cells
grown in T-75 flasks (about 0.5 to 1.0 X i07 cells) and used at
passages 3 through 6. In experiments carried out in serum-free
media, serum was not added but all other additions were as above.
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Northern blot analysis
Total RNA was isolated using RNA-stat6° (Tel-Test "B" Inc.).
Total cellular RNA was fractionated on 1% agarose-formalde-
hyde gels and transferred onto nylon filters (Gene-Screen, Du-
Pont) in 0.025 M Na phosphate buffer, pH 6.5. Twenty micro-
grams of total RNA were loaded per lane. Membrane filters were
dried at 80°C for 15 minutes, and RNA was fixed by crosslinking
in a UV Stratalinker-1800 (Stratagene) with 1,800 U. Membrane
filters were then prehybridized for six hours at 42°C in 50%
deionized formamide (vol/vol), 0.04% polyvinylpyrrolidone (wt/
vol), 0.04% bovine serum albumin (wt/vol), 0.04% Ficoll (wt/vo!),
5 x SSC, 1% SDS (wtlvol) and denatured salmon sperm DNA
(100 g/m1). Full length murine probes for COX I and COX II
were radiolabeled with 32P by the random priming method.
Hybridization was performed at 42°C for 18 to 20 hours in a
solution containing: 50% deionized formamide (vol/vol), 0.02%
polyvinylpyrrolidone (wt/vol), 0.02% bovine serum albumin (wt/
vol), 0.02% Ficoll (wt/vol), 5 x SSC, 1% SDS (wt/vol), and
denatured salmon sperm DNA at 100 g/ml. Filters were washed
twice at room temperature for five minutes in 2 X SSC and twice
at 60°C for 30 minutes in 2 x SSC + 0.1% (wt/vol) SDS and then
exposed overnight to Kodak XAR film at — 70°C with intensifying
screens. To control for variability in the loaded quantity of RNA,
all membranes were probed with a 550 bp Hind III-Xba 1
restriction fragment of pRc GAP to determine the steady state
levels of GAPDH gene-related sequences [20] and used to correct
for mRNA for COX I and COX II.
PGE2 determination
PGE2 in the media was determined by stable isotope gas
chromatography-mass spectrometry (GC-MS) as previously de-
scribed [19]. At the end of predetermined times, the medium was
removed and spiked with 25 to 50 ng tetradeuterated PGE2
(d4-PGE2). The medium was then acidified to pH 3.5,and PGE2
was extracted by I ml octadecyl columns (Baker). Extracts were
derivatized for GC-MS analysis. The samples were analyzed as the
pentafiuorobenzyl methoxime trimethylsilyl ether by negative ion
chemical ionization using methane as the reagent gas. Ions
monitored were m/z 524 (d0-PGE2) and m/z 528 (d4-PGE2). Mass
spectrometry was performed on a Hewlett-Packard 5985B spec-
trometer using a 25 m Ultra 1 (Hewlett Packard) capillary
column, and data collection and analysis were performed using
Vector 2 (Teknivent, St. Louis, MO, USA) software.
Preparation of cell lysates, Western blotting and
immunoprecipitation
Cells were stimulated with interleukin-1/3 or vanadate for 0 to
30 minutes, washed twice with ice-cold PBS and lysed in ice-cold
extraction buffer containing 2 mic EGTA, 2 mrvi EDTA, 10 mM
NaF, 1 mM Na4P2O7, 0.1 mri PMSF, 2 m sodium (ortho)
vanadate, 100 kaliikrein U/mi of aprotinin, 20 M pepstatin, and
200 LM leupeptin in 25 m'vi Tris/HC1, pH 7.4. Protein concentra-
tion was quantitated by the I3CA method [21] and 10 gs of total
protein per lane were run on 12% SDS-polyacrylamide gel.
Proteins were transferred to Immobilon (Millipore) membranes
and immunobiotted with antiphosphotyrosine, anti-IKBa and
anti-ERK2 antibodies at the appropriate concentrations in 1%
blotto.
Materials
IL-1f3 agarose conjugated anti-phosphotyrosine and anti-phos-
photyrosine rabbit polyclonal IgG were purchased from Upstate
Biotechnology (Lake Placid, NY, USA) and d4-PGE2 was pur-
chased from Cayman Chemical. Anti-IKBa antiserum was a gift of
Dr. W. Greene of the Gladstone Institute. IRK2 antisera were a
gift of Dr. J. Lawrence of Washington University. Na4P2O7, NaF,
sodium (ortho) vanadate, pepstatin, leupeptin, and aprotinin were
from Sigma (St. Louis, MO, USA). Ammonium (meta) vanadate
was obtained from Fluka and genistein was from Calbiochem.
Gene Screen was from DuPont and murine cDNA probes ligated
in BlueScript SK for COX I and COX II were a gift of Dr. Karen
Seibert, Monsanto Company (St. Louis, MO, USA). The COX I
cDNA was excised from the plasmid as a Barn HI-Hind III digest.
The COX II cDNA was isolated by a Kpn I-Barn HI digest. The
DNA was purified from 1% agarose gels by Gene Clean (Bio 101).
Results
To demonstrate the necessity for serum to express the full
response of IL-113 with respect to PGE2 biosynthesis, we incu-
bated mesangial cells, which had been serum starved for 24 hours,
and measured the PGE2 response to IL-13 as a function of time
up to six hours. A control was obtained at time 0, and a parallel
incubation, in which cells were serum starved for 24 hours and
then incubated with 15% fetal calf serum for six hours, was also
added. Figure 1A demonstrates that IL-1/3 failed to increase
significantly the amount of PGE2 secreted into the media by six
hours, whereas the addition of 15% fetal calf serum allowed the
increase in PGE2 production similar to normal conditions with
fetal calf serum (data not shown). These data confirm data
previously published [22]. Figure lB illustrates a Northern anal-
ysis of cellular mRNA which has been harvested over the same
time course of IL-1j3 stimulation and probed for both COX I and
COX II messages as well as the housekeeping message for
glyceraldehyde 3-phosphate dehydrogenase (GAPDH). This fig-
ure shows that there is a strong correlation between the amount of
PGE2 released into the external environment and the levels of
expression of CON II message in the mesangial cell.
In view of this requirement for serum, we evaluated the
response of tnesangial cells grown in 15% FCS to the tyrosine
kinase inhibitor, genistein. Dose dependent inhibition is demon-
strated in Figure 2. Control cells were stimulated with interleu-
kin-1/3 for 18 hours and in the absence of genistein. The dose
dependent inhibition of PGE2 release into the media after 18
hours of exposure to both interleukin-1/3 and genistein is demon-
strated in Figure 2, with a concentration of 30 g/ml of genistein
resulting in a greater than 95% inhibition of PGE2 release into the
media. The IC50 for genistein was about 7 g/ml in this experi-
ment and represents a mean of two experiments in duplicate. In
these experiments, 18 hours was chosen since the maximal PGE2
release occurred at 18 to 24 hours and probably relates to maximal
increases in COX II protein.
In order to correlate the PGE2 levels with mRNA levels, we
also performed Northern analysis for both COX I and COX II
gene transcripts in response to interleukin-1 in the mesangial cell
as a function of the genistein concentration in the incubation
media. These experiments were carried out at three hours, which
is the time required for maximum levels of induction for the COX
II mRNA which has been previously described in our laboratory
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Fig. 1. Time-dependent PGE2 and COX II mRNA stimulation in serum-deprived rat mesangial cells treated with IL-I 13. Twenty-four hours before
experiment cells were maintained in serum-free medium. Then media were removed and cells were exposed to IL-13 (10 U/mi) in fresh serum-free
medium at indicated times. (A) PGE2 released into media. (B) Northern analysis of total RNA (20 g/lane) isolated from cells cultured in serum-free
medium for 24 hours then exposed to IL-113 (IOU/mi) at indicated times. In the lane which serum is marked as +, serumwas added for 6 hours to serum
starved cells.
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[18]. In cells that have not been exposed to interleukin-113, Figure
3 shows the low levels of expression of the COX II mRNA
corrected for the housekeeping gene GAPDH. This control level
of expression was not significantly affected by increasing the
concentration of genistein as shown in Figure 3. In contrast,
however, the IL-1/3 stimulation of the COX II gene transcript
showed a dose dependent inhibition, again with the IC50 of about
8 xgIml. These experiments demonstrated a strong and close
correlation between the ability of genistein to inhibit both PGE2
release into external environment in response to IL-113 and its
ability to inhibit the expression of the COX II gene transcript in
response to IL-1/3. Of note was that the effect of genistein or
IL-1f3 on COX I mRNA expression (while not shown here) was
also quantitated and showed no effect.
To demonstrate that a different tyrosine kinase inhibitor also
inhibits the IL-1f3 induced COX II gene transcript, we also
repeated these experiments in the presence and absence of
herbimycin A. Herbimycin A was used at two concentrations, 0.2
g/ml and 2.0 jxg/ml. Figure 4 demonstrates the induction of the
COX II gene transcript by IL- 1/3 and no effect on the COX I gene
transcript. It also shows that herbimycin A at both concentrations
inhibited the ability of interleukin-1 to induce the COX II gene
transcript, demonstrating that with a different tyrosine kinase
inhibitor, the induction of the COX II gene transcript by IL-1/3
was suppressed by tyrosine kinase inhibition, We acknowledge,
however, that both herbimycin and genestein could have effects on
the cell biology of which we are unaware. Figure 5 illustrates the
proteins which have been phosphorylated on tyrosine in response
to IL-13 in whole mesangial cell lysates. Here, mesangial cells are
exposed to concentrations of 10 U/ml of IL-1f3 and cells harvested
at different time intervals. The cell lysates were then subjected to
Western analysis using an antiphosphotyrosine antibody. Figure 5
shows the major proteins phosphorylated in response to IL-1p. It
clearly demonstrates proteins of apparent molecular weight as
0 0.1 1.0 10 30
Genistein, p.g/ml
Fig. 3. Effect of genistein on expression of COX 11 gene in mesangial
cells—dose response curee. The figure shows results of densitometric
scanning of Northern analysis of total RNA isolated from control cells ()
and cells stimulated with IL-l$ (•) (10 U/ml) and genistein at indicated
concentrations. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is
used as housekeeping transcript.
114, 105,85,39 and 28 kD phosphorylated in response to lL-113 as
a function of time. Clearly, there were other proteins phosphor-
ylated in response to IL-i /3, and while these may be important we
have focused on the major proteins phosphotylated in this figure.
Similar experiments carried out with serum starved cells did not
demonstrate phosphorylation of tyrosylated proteins in response
to IL-1p. Since these experiments have demonstrated that ty-
rosine phosphorylation was an important signal transduction
mechanism for the expression of the COX II gene transcript, we
asked the question, "Would an inhibitor of tyrosine phosphatases
also stimulate the induction of the COX II gene transcript?"
Therefore, we incubated mesangial cells with and without ammo-
nium metavanadate over the concentration range of 1 to 100 I.LM
in the presence and absence of IL-l/3. Figure 6 demonstrates that
after three hours of incubation with 1 and 10 jiM ammonium
metavanadate, there was an induction of COX II gene transcript
without an induction of the COX I gene transcript, very similar to
500
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Genistein, tg/mI
2.00 -
1.60
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0
I0
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0.00
30
Fig. 2. Effect of genistein on prostaglandin production in mesangial cells—
dose response curee. The figure shows POE2 concentration in media of
mesangial cells after 18 hours exposure to IL-1/3 (10 U/mI) and genistein
at indicated concentrations.
I
IL-113 + +
Herb-A 2.0 2.0
+
.2 .2 0 0
Fig. 4. Effect of herbimycin A on expression of COX I and COX II genes in rat mesangial cells. Northern analysis of 20 sg of total RNA isolated from
mesangial cells after 3 hours exposure to IL-1f3 (10 U/mI); IL-lp (10 U/mI) + herbimycin A at concentration 0.2 sWml and 2 jsg/ml.
0' 5' 15' 30' 60'
Fig. 5. Time course of tyrosine phosphotylation
of proteins from mesangial cells exposed to IL-
1(3. Equal amounts of protein (40 .rg/lane)
were separated on PAGE gel, then
transferred onto Immobilon membrane.
Protein immunoblots were analyzed with
polyclonal rabbit antibodies to
phosphotyrosine.
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the qualitative induction by IL-lp in previous experiments. Van-
adate at a concentration of 100 1.LM did not appear to stimulate
COX II mRNA. The addition of IL-113 to ammonium (meta)
vanadate caused a further increase in the amount of message for
the COX II gene transcript, without any change in the COX I
gene transcript. Vanadate at a concentration of 100 M appeared
to inhibit the effect of IL-lp, and thus this concentration may be
toxic to the cells. Western analysis of lysates from mesangial cells
4.,. S4 %s
exposed to 10 xM vanadate (which is stimulatory for COX II
mRNA) demonstrates that the drug induces phosphorylation of a
few tyrosyiproteins in a time dependent fashion (Fig. 7). The
phosphorylation state of the predominantly phosphorylated ty-
rosyiprotein of apparent molecular weight 39/40 kD increases
several-fold at two minutes of exposure and declines thereafter.
These experiments suggest that by inhibition of a phosphatase, we
could induce the COX II gene transcript without the addition of
IL-1/3 and that when both are present together, the effects are at
least additive. The two candidate proteins we evaluated which had
similar molecular weights were 1KB and ERK2.
To determine if 1KB kinetics was altered in the rat mesangial
cell stimulated with IL-1j3, we cultured cells in the presence of
serum and serum deprived for 24 hours, then stimulated with
IL-1f3. We then obtained cell lysates at zero (control), 5, 15, 30
and 60 minutes after addition of IL-1f3, chromatographed on
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Fig. 6. Effect of vanadate on COX I and COX II gene expression in rat mesangial cells. Northern analysis of total RNA (20 pg/lane) isolated from cells
exposed for 3 hours to IL-lp (10 U/mI) and IL-1/3 (10 U/mI) and vanadate (m-V04) at indicated concentrations in pM,
0 2' 5' 15' 30' 60'
106—
80.0—
49.5 —
— p 39
32.7 —
27.5 —
Fig. 7. Time course of lyrosine phosphorylation
of protein from rat mesangial cells exposed to
JO psi ammonium (meta) vanadate. Equal
amounts of protein (20 pg/lane) were
separated on PAGE gel and then transferred
onto Immobilon membrane. Protein
18.5 — immunoblot was analyzed with polyclonal
rabbit antibodies to phosphotyrosine.
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Fig. 8. Immunoblot of cell lysates with anti -I ,.zBa antiserum. Cell lysates from cells serum starved for 24 hours and exposed to IL-113 for 0, 5, 15, 30 and
60 minutes were chromatographed by PAGE and blotted with anti-IKBcs antiserum. Lysates from serum replete exposed to IL-1J3 for 0, 15 and 60
minutes are shown for comparison.
C 5' 15' 30' 60'
Fig. 9. Immunoblot with anti ERK2 antibody of proteins immonoprecipated with agarose conjugated antiphosphotyrosine antibody. Lysates from cells
treated with IL-113 for 0, 5, 15, 30 and 60 minutes were immunoprecipated with antiphosphotyrosine antibody and precipated proteins analyzed by
Western analysis using an anti-ERK2 antibody.
PAGE and performed Western analysis using anti-IKBcs anti-
serum. Figure 8 shows that IxBcw was detected in control cells
cultured both in the presence and absence of serum, disappeared
from the cell lysate at 15 minutes, and returned towards initial
levels at 30 to 60 minutes. The apparent molecular weight of the
protein detected by the IKBa antiserum was 36/37 kD and
consistent with the size detected in the rat [23]. These experiments
suggest activation of IKBa by IL-ip in the rat mesangial cell when
cultured either in the presence of serum or when serum starved.
They further suggest no differences in the kinetics of proteolytic
loss whether the cells were cultured in the absence or presence of
serum.
To determine if the 39/40 kD protein tyrosine phosphorylated
was ERK2, we immunoprecipitated tyrosine phosphorylated pro-
teins with agarose-conjugated antiphosphotyrosine antibody and
examined the precipitated proteins by Western analysis using an
anti-ERK2 antibody. Figure 9 shows these results. It can be seen
that the anti-ERK2 antibody detected minimal proteins at time 0,
but at increasing time of exposure of mesangial cells to IL-1J3
increasing amounts of tyrosine phosphorylated ERK2 were de-
tected in lysates which peaked at 30 minutes.
Discussion
Multiple cellular events result from the binding of extracellular
ligands to cell surface receptors. Biological specificity ensues by
the highly specific protein interactions occurring along the signal
transduction cascade. The binding of extracellular ligands to the
extracellular domains of their complimentary receptors leads to
transphosphorylation and the recruitment of proteins that consti-
tute the signaling cascade. Interleukin-1/3 is a comitogen for
mesangial and other cells in that it requires serum to stimulate cell
proliferation and DNA synthesis for certain genes [24]. This
serum requirement for IL-113 to initiate the signal transduction
cascade is incompletely understood. It is possible that two sepa-
rate membrane events are required, that is, IL-lp binding to the
IL-I type I receptor and additional priming factors existing in
serum, to initiate the signaling pathway leading to a phosphory-
lation/dephosphorylation cascade.
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Expression of genes encoded by two serine/threonine protein
kinases, sgk and snk, is reported to be regulated by serum [25, 26].
In addition, protein kinase 34cdc2 activated in the presence of
serum plays a key role in initiation of fibroblast proliferation and
DNA synthesis [27]. This kinase phosphorylates a number of
proteins, among others p6Oc.src RNA polymerase II, and cyclin A
and B [28], and it is postulated that intracellular protein tyrosine
kinases of the src family are recruited in post-receptor evefits of
many cytokines whose receptors have no intrinsic protein kinase
domain. In addition, in COS-7 cells, serum induces translocation
of mitogen-activated protein kiriase to the nucleus, where it may
in this subcellular distribution phosphorylate transcriptional fac-
tors [29]. In mesangial cells, IL-1J3 increases prostaglandin en-
doperoxide synthase 2 (COX II) mRNA and prostaglandin E2
production [18, 191. This increase requires serum, as is demon-
strated in Figure 1A and lB. Here it can be seen that IL-1/3 does
not significantly increase the levels of COX II message in mesang-
ial cells serum starved for 24 hours. Mesangial cells serum starved
do not proliferate to the same extent as in the presence of serum.
This suggests that there is a requirement for some unknown
growth factor(s) present in serum for both the increase in growth
and the increase in COX II mRNA transcription. Since many
growth factors mediate, in part their cellular signaling through
tyrosine kinase activity, we evaluated two inhibitors of cellular
tyrosine kinases on IL-1f3 signaling by determining their effective-
ness in inhibiting COX II induction. The isofiavone genistein, an
inhibitor of protein tyrosine kinases, reduces to basal levels both
IL-113 stimulated PGE2 (Fig. 2) and COX II mRNA (Fig. 3). This
effect was dose dependent with 1C50's of 7 and 8 gIm1, respec-
tively. The biologically effective concentrations observed in these
experiments are consistent with the concentrations required to
inhibit phosphorylation of pp6osrc and autophosphorylation of the
EGF receptor [30, 31]. We also used another protein tyrosine
inhibitor, herbimycin A, whose mechanism of action occurs
through selective binding to the carboxy-terminus of src-related
protein tyrosine kinases via sulfhydryl groups to increase their rate
of degradation [32—341. The inhibitory effect of herbimycin A at
concentrations of 0.2 and 2.0 xg/ml confirms that activation of
cellular tyrosine kinases is required for IL-1/3 up-regulation of the
COX II message. These observations are similar to the effect of
IL-1f3 on iNOS expression in that the induction is also inhibited by
genistein and herbimycin A [35] but differs in that the induction of
iNOS is enhanced in the absence of serum [36]. The phosphory-
lation state of proteins phosphorylated on tyrosine in cells repre-
sents a balance between phosphorylation via tyrosine kinases and
dephosphorylation by protein tyrosine phosphatases. Vanadate at
concentrations of 1 to 10 xM, which is inhibitory to protein
tyrosine phosphatases [37, 38] not only augments IL-1f3 induced
increase of level of COX II mRNA, but by itself increases the
COX II message. Therefore, phosphorylation on tyrosine residues
is an important event in the IL-1/3/serum signaling pathway
leading to the expression of COX II, and both protein tyrosine
kinases and protein tyrosine phosphatases activities are involved.
The effect of vanadate alone, however, may suggest that the IL-1/3
signaling processes could involve regulation of a protein tyrosine
phosphatase rather than a protein kinase. This hypothesis would
necessitate that both tyrosine kinase and phosphatase are consti-
tutively active, probably because of the comitogenic effect of
serum and that the addition of IL-lp inhibits protein tyrosine
phosphatase activity. This is precedent for this hypothesis since it
was demonstrated in human foreskin fibroblasts (FS-4) and
MRC-5 cells (human embryonic lung fibroblasts) that TNFa and
IL-1p could inactivate a redox-sensitive protein phosphatase
during the early events in th signal transduction cascade [39].
The lack of stimulatoty effect of IL-I f3 in serum-deprived mesan-
gial cells could then occur because of a low level of protein kinase
activity engendered by serum deprivation. Phosphorylation of
tyrosyiproteins is observed in the presence of IL-1/3 in a number
of diverse cell lines [12, 14, 40—43]. An overlapping pattern of
proteins phosphorylated on tyrosine residues suggests common
signaling pathways for ligands binding to hematopoietic receptors.
However, the usually large spectrum of phosphotyrosylproteins
occurring in response to external stimuli has complicated investi-
gations of these protein functions. Western analysis of proteins
from mesangial cells treated with IL-1p showed a transient
increase of phosphorylation on tyrosine residues of several un-
characterized proteins (Fig. 5). A comparison of the pattern of
phosphotyrosylproteins occurring in cells stimulated with IL-lp
and 10 LM vanadate revealed important differences: vanadate-
dependent phosphorylation occurs more rapidly than that ob-
served in IL-113 stimulated cells and is more selective in that only
three phosphotyrosyiproteins are detected. Transient phosphory-
lation of a 39/40 kD protein is common to both experimental
maneuvers. This suggests that the 39/40 kD phosphotyrosylprotein
may play a crucial, regulatory role in the signaling cascade
involved in the regulation of COX II mRNA by IL-i /3.
Inducible gene expression in eukaryotes is regulated by the
activity of trans-acting activator proteins such as NFKB [441.
NFKB has been reported to contribute to the IL-1f3 signaling
cascade in mesangial cells [45]. Activation of NFKB involves the
release of the inhibitory subunit 1KB from the DNA binding
subunits p50/65 NFKB (heterodimer) or the p50/SO homodiner
[46—50]. To address the possibility that the 39/40 kD protein
phosphorylated on tyrosine in the mesangial cell may represent
the phosphorylated, dissociated form of 1KB, we carried out
immunoblots of mesangial cell lysates. The experiments suggest
that NFKB was released to translocate to the nucleus to bind to
cis-acting regions of the COX II gene leading to transcriptional
activation of the gene, since IKBa was degraded in the cell lysates
within 15 minutes of exposure to IL-113 in both serum replete and
starved cells. This is consistent with the known kinetics of
activated 1KB [51]. Our experiments suggest, however, that the
protein detected by the antiphosphotyrosine antibody was not
IKBa because of differences in apparent molecular weight. Since
the message for COX II does contain the consensus motif
5'-GGGRNNYYCC-3' in its promoter [52], this suggests that it
does contain the NFKB-binding motif [531 and further suggests
that NFKB binding may not be sufficient to activate the message
fully.
Another possibility for the 40 kD protein could be one of the
family of extracellular signal regulated kinases (ERK). At least
two of the ERKs are activated in response to growth factors. Their
activation correlates with tyrosine phosphorylation but also de-
pends on additional modifications. Thus, this family of kinases
may serve as intermediates that depend on tyrosine phosphoryla-
tion to activate serine-threonine phosphorylation cascades [54].
Our experiments demonstrate that IL-1/3 triggers the tyrosine
phosphorylation of ERK2 which can be detected by five minutes
of exposure of mesangial cells to the cytokine.
The experiments executed here demonstrate that IL-1f3 induces
1362 Rzymkiewicz et a!: Tyrosine phosphoiylation and COX II expression
the mRNA for COX II without affecting mRNA for CDX I. This
effect can be inhibited by serum starvation and inhibition of
tyrosine kinase. It can be mimicked by inhibition of protein
tyrosine phosphatases, and the combination of IL-1/3 and phos-
phatase inhibitor was additive with respect to induction of mRNA
for CDX II in the rat mesangial cell. The experiments suggest that
tyrosine phosphorylation of ERK2 may be crucial to these bio-
chemical events.
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